HBV Drug Resistance Substitutions Existed before the Clinical Approval of Nucleos(t)ide Analogues: A Bioinformatic Analysis by GenBank Data Mining
Abstract
Share and Cite
Xu, X.; Xiang, K.; Su, M.; Li, Y.; Ji, W.; Li, Y.; Zhuang, H.; Li, T. HBV Drug Resistance Substitutions Existed before the Clinical Approval of Nucleos(t)ide Analogues: A Bioinformatic Analysis by GenBank Data Mining. Viruses 2017, 9, 199. https://doi.org/10.3390/v9080199
Xu X, Xiang K, Su M, Li Y, Ji W, Li Y, Zhuang H, Li T. HBV Drug Resistance Substitutions Existed before the Clinical Approval of Nucleos(t)ide Analogues: A Bioinformatic Analysis by GenBank Data Mining. Viruses. 2017; 9(8):199. https://doi.org/10.3390/v9080199
Chicago/Turabian StyleXu, Xizhan, Kuanhui Xiang, Mingze Su, Yao Li, Wei Ji, Yutang Li, Hui Zhuang, and Tong Li. 2017. "HBV Drug Resistance Substitutions Existed before the Clinical Approval of Nucleos(t)ide Analogues: A Bioinformatic Analysis by GenBank Data Mining" Viruses 9, no. 8: 199. https://doi.org/10.3390/v9080199
APA StyleXu, X., Xiang, K., Su, M., Li, Y., Ji, W., Li, Y., Zhuang, H., & Li, T. (2017). HBV Drug Resistance Substitutions Existed before the Clinical Approval of Nucleos(t)ide Analogues: A Bioinformatic Analysis by GenBank Data Mining. Viruses, 9(8), 199. https://doi.org/10.3390/v9080199